NIH-funded research NIH-funded research

Understanding how specific cells help close the urethra in newborn boys

Official title: Defining the role of Sf1 in urethral closure

Funded at University of Missouri-Columbia · NIH-11086291 · Data updated 2026-11-12

This study is looking at how certain cells in the penis help with the closure of the urethra, which is important for understanding hypospadias, a condition that affects baby boys, and it hopes to find better ways to prevent and treat it.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Missouri-Columbia
NIH-funded
Lab location1 site (Columbia, United States)
Project startJuly 15, 2024
Project endJuly 14, 2027
Funding year2024
Award (this year)$249,000
NIH project number4R00DK132460-03
Project IDNIH-11086291 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are newborn boys diagnosed with hypospadias or those at risk of developing this condition.

Less likely to help

Patients who are not newborn boys or those without a diagnosis of hypospadias may not benefit from this research.

What this research studies

This research investigates the role of a specific cell type in the penis that expresses a key enzyme involved in hormone signaling, which is crucial for the proper closure of the urethra. The study focuses on understanding how these cells communicate with surrounding tissues and how they respond to hormones like testosterone and dihydrotestosterone. By exploring the mechanisms behind urethral closure, the research aims to uncover the causes of hypospadias, a common birth defect affecting newborn boys. The findings could lead to better prevention and treatment strategies for this condition.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for hypospadias, potentially reducing the incidence of this birth defect.

How similar studies have gone: While the specific role of Sf1 in urethral closure is being explored for the first time, similar research on hormone signaling in development has shown promising results in understanding other birth defects.

Where this research is happening

  • University of Missouri-Columbia
    Columbia, United States
    Active

Researchers

  • Principal investigator: Amato, Ciro Maurizio — University of Missouri-Columbia
  • Study coordinator: Amato, Ciro Maurizio

Related research

Other NIH-funded projects on the same topics.

  • Boosting immune response to fight cancer

    This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-9868156

  • Interface between immune cells and scarring in the eye

    This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11609392

  • Understanding cell-cleanup problems in C9ORF72-related ALS/FTD

    Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11606636

  • Molecular clues to endometriosis-related infertility

    This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11595518

  • A universal Shigella vaccine using SAVE to protect people of all ages

    A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11464403

  • Biomarkers that predict osteoarthritis risk in people at higher risk

    A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11461903

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.